Pfizer: Address Knowledge Gaps in Growth Hormone Deficiency
url to RFP:  https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-07/GMG_2020RD_L_Education_GrowthHormoneDeficiency_UnitedStates.pdf?DWuM0kAN4bbTLY4wojtsbAYiEm5xGmqM

Through this RFP, Pfizer supports educational programs for pediatric endocrinologists.
Projects that will be considered for Pfizer support will focus on:

• Improving the understanding of the safety and efficacy of growth hormone (GH) administered once-daily in managing patients with short stature.
• Improving the understanding of the relationship between adherence and treatment outcomes.
• Increasing awareness of the emerging science of long-acting growth hormone to improve the understanding of their efficacy, safety, and potential clinical applicability.